Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Michael Philip Hagan, MD

LICENSE # 0101057220
  Michael.Hagan@va.gov

Issue Date: 2/5/1998
Expiration Date: 5/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/2/2016
University of Florida College of Medicine - Gainesville, FL
Rank: Associate Professor
Years: 1995-1998

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Full Professor
Years: 1998-Present

Academic Appointments - Non-US
Last Updated 5/2/2016
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/2/2016
Epidermal Growth Factor and Ionizing Radiation Up-regulate the DNA Repair Genes XRCC1 and ERCC1 in DU145 and LNCaP Prostate Carcinoma through MAPK Signaling.
Radiation Research
Volume: 159
Date: 03 2001

Radiation-Stimulated ERK1/2 and JNK1/2 Signaling Can Promote Cell Cycle Progression in Human Colon Cancer Cells.
Cell Cycle
Volume: 28
Date: 08 2001

Pharmacological inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms.
CAncer Biol. Ther.
Volume: 1
Date: 03 2002

Inhibitors of MEK1/2 interact synergistically with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells.
Cancer Biol. Ther.
Volume: 1
Date: 05 2002

Stress and radiation-induced activation of multiple intracellular signaling pathways.
Radiation Research
Volume: 159
Date: 01 2003

Ionizing Radiation Causes a Dose-Dependent Release of Transforming Growth Factor {alpha} In vitro from Irradiated Xenografts and during Palliative Treatment of Hormone-Refractory Prostate Carcinoma.
Cancer Res
Volume: 10
Date: 09 2003

RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Int. J. of Radiation Oncology Biol. Phys.
Volume: 57
Date: 11 2003

MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion.
Int. Jour. Radiation Biology
Volume: 77
Date: 01 2005

Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy.
Int. J. Radiation Oncology Biol. Oncol. Phys.
Volume: 59
Date: 01 2005

Radiation-Stimulated ERK1/2 and JNK1/2 Signaling Can Promote Cell Cycle Progression in Human Colon Cancer Cells.
Cell Cycle
Volume: 4
Date: 03 2005